(Q50519033)

English

Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma

scientific article published on July 15, 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/7607934

Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma (English)

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

total body irradiation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607934

13 June 2024

author name string

G. S. Sibley

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607934

13 June 2024

A. J. Mundt

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607934

13 June 2024

S. Goldman

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607934

13 June 2024

J. Nachman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607934

13 June 2024

C. Reft

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607934

13 June 2024

R. R. Weichselbaum

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607934

13 June 2024

D. E. Hallahan

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607934

13 June 2024

L. Johnson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607934

13 June 2024

language of work or name

0 references

publication date

1 July 1995

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/7607934

15 July 1995

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7607934

13 June 2024

full work available at URL

https://api.elsevier.com/content/article/PII:036030169500011M?httpAccept=text/xml

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

https://api.elsevier.com/content/article/PII:036030169500011M?httpAccept=text/plain

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/7607934

32

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/7607934

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/7607934

1127-1135

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/7607934

Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience

1

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution

2

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital experience, 1962 to 1988

3

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

4

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma

5

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases

6

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma

8

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Sites of relapse in patients with neuroblastoma following bone marrow transplantation in relation to preparatory "debulking" treatments.

9

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Dose response analysis of pediatric neuroblastoma to megavoltage radiation

10

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Pediatric neuroblastoma: postoperative radiation therapy using less than 2000 rad

11

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Myeloablative combination chemotherapy without total body irradiation for neuroblastoma

14

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation

15

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy

18

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study

19

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer

20

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age

21

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study

22

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?

23

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study

25

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience

27

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

28

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Cancer incidence, survival, and mortality for children younger than age 15 years

30

1 reference

10.1016/0360-3016(95)00011-M

https://api.crossref.org/works/10.1016/0360-3016(95)00011-M

13 June 2024

Identifiers

10.1016/0360-3016(95)00011-M

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/7607934

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/7607934

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50519033&oldid=2177914538"